Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥133.43 Million ≈ $19.52 Million USD) by net assets (CN¥7.16 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600572 net asset quality score to measure how much of total assets are equity-financed.

Zhejiang CONBA Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang CONBA Pharmaceutical Co Ltd (600572) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Scatec Solar OL OL:SCATC	0.013x
Lonking Holdings Limited F:C9IB	0.040x
Jiangsu Zhangjiagang Rural Commercial Bank Co Ltd SHE:002839	0.253x
LANXESS Aktiengesellschaft F:LXS	0.013x
Intershop Holding AG SW:ISN	0.014x
Shenzhen Kingdom SCI Tech Co Ltd SHG:600446	0.005x
Aurora Optoelectronics Co Ltd SHG:600666	-0.037x
Sanoma Oyj HE:SANOMA	0.237x

Annual Cash Flow Conversion Efficiency for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang CONBA Pharmaceutical Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥7.15 Billion ≈ $1.05 Billion	CN¥942.61 Million ≈ $137.93 Million	0.132x	-10.02%
2024-12-31	CN¥6.91 Billion ≈ $1.01 Billion	CN¥1.01 Billion ≈ $148.16 Million	0.146x	+19.80%
2023-12-31	CN¥7.35 Billion ≈ $1.08 Billion	CN¥898.64 Million ≈ $131.50 Million	0.122x	-22.50%
2022-12-31	CN¥7.32 Billion ≈ $1.07 Billion	CN¥1.16 Billion ≈ $169.08 Million	0.158x	+31.05%
2021-12-31	CN¥7.39 Billion ≈ $1.08 Billion	CN¥889.94 Million ≈ $130.23 Million	0.120x	-48.47%
2020-12-31	CN¥5.35 Billion ≈ $782.79 Million	CN¥1.25 Billion ≈ $182.87 Million	0.234x	+24.76%
2019-12-31	CN¥4.94 Billion ≈ $723.27 Million	CN¥925.50 Million ≈ $135.43 Million	0.187x	+98.73%
2018-12-31	CN¥5.79 Billion ≈ $847.64 Million	CN¥545.78 Million ≈ $79.86 Million	0.094x	-22.70%
2017-12-31	CN¥5.84 Billion ≈ $855.11 Million	CN¥712.27 Million ≈ $104.23 Million	0.122x	-43.59%
2016-12-31	CN¥4.49 Billion ≈ $656.77 Million	CN¥969.71 Million ≈ $141.90 Million	0.216x	+18.66%
2015-12-31	CN¥4.57 Billion ≈ $668.05 Million	CN¥831.26 Million ≈ $121.64 Million	0.182x	-0.61%
2014-12-31	CN¥3.37 Billion ≈ $493.18 Million	CN¥617.43 Million ≈ $90.35 Million	0.183x	+101.72%
2013-12-31	CN¥2.59 Billion ≈ $379.22 Million	CN¥235.36 Million ≈ $34.44 Million	0.091x	-9.81%
2012-12-31	CN¥2.44 Billion ≈ $357.14 Million	CN¥245.76 Million ≈ $35.96 Million	0.101x	-13.82%
2011-12-31	CN¥1.61 Billion ≈ $235.90 Million	CN¥188.36 Million ≈ $27.56 Million	0.117x	+59.22%
2010-12-31	CN¥1.72 Billion ≈ $251.12 Million	CN¥125.93 Million ≈ $18.43 Million	0.073x	-45.11%
2009-12-31	CN¥1.15 Billion ≈ $167.90 Million	CN¥153.39 Million ≈ $22.45 Million	0.134x	+24.75%
2008-12-31	CN¥919.66 Million ≈ $134.58 Million	CN¥98.56 Million ≈ $14.42 Million	0.107x	+14.52%
2007-12-31	CN¥854.74 Million ≈ $125.08 Million	CN¥79.98 Million ≈ $11.70 Million	0.094x	-17.51%
2006-12-31	CN¥627.66 Million ≈ $91.85 Million	CN¥71.20 Million ≈ $10.42 Million	0.113x	-42.62%
2005-12-31	CN¥595.08 Million ≈ $87.08 Million	CN¥117.65 Million ≈ $17.22 Million	0.198x	+70.62%
2004-12-31	CN¥565.05 Million ≈ $82.68 Million	CN¥65.47 Million ≈ $9.58 Million	0.116x	-58.37%
2003-12-31	CN¥239.44 Million ≈ $35.04 Million	CN¥66.64 Million ≈ $9.75 Million	0.278x	--

About Zhejiang CONBA Pharmaceutical Co Ltd

SHG:600572 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.58 Billion

CN¥10.76 Billion CNY

Market Cap Rank

#7002 Global

#1474 in China

Share Price

CN¥4.24

Change (1 day)

-0.93%

52-Week Range

CN¥3.88 - CN¥4.94

All Time High

CN¥10.42